GlassScriptPhysician profile
Benjamin R Mccullar
NPI 1750732707
$3,295.35
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,054 · 2020: $460 · 2021: $709 · 2022: $31.70 · 2023: $16.80 · 2024: $23.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $40.47.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $40.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,315.60 | 2019-2021 | |
| Smith+Nephew, INC. | $211.31 | 2019-2024 | Stravix, Oasis, Grafix Pl |
| Organogenesis INC. | $177.60 | 2019-2022 | |
| Dynasplint Systems INC. | $164.12 | 2021 | |
| Celularity INC. | $112.00 | 2019 | |
| Abbott Laboratories | $50.09 | 2020 | |
| Triad Life Sciences INC. | $44.62 | 2021 | |
| Melinta Therapeutics, LLC | $37.48 | 2021 | |
| Axogen | $36.96 | 2019 | |
| Integra Lifesciences Corporation | $34.84 | 2019-2021 | |
| Paragon 28, INC. | $33.70 | 2019 | |
| Baxter Healthcare | $19.66 | 2019 | |
| Acumed LLC | $14.26 | 2021 | |
| Medartis INC. | $13.20 | 2021 | |
| Zyla Life Sciences, INC. | $12.41 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $11.22 | 2019 | |
| Orthofix Medical, INC. | $6.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Mccullar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.